SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 61.88
+0.92 (1.51%)
At close: Apr 8, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 4.82 billion as of April 7, 2026. Its market cap has increased by 91.28% in one year.
Market Cap
4.82B
Enterprise Value
4.18B
Revenue
819.09M
Ranking
n/a
PE Ratio
44.21
Stock Price
61.88
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has increased from 4.48B to 4.82B, an increase of 7.54%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 4.82B | 17.14% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.58B |
| Cowealth Medical China | 8.02B |
| Shanghai Runda Medical Technology | 7.40B |
| Beijing Strong Biotechnologies,Inc. | 6.89B |
| Maccura Biotechnology Co.Ltd | 6.42B |
| Thalys Medical Technology Group | 5.05B |
| Guangdong Hybribio Biotech | 4.19B |
| Shanghai Labway Clinical Laboratory | 3.90B |